Healthcare (Women's Health)

in committee · United States · Senate May 11, 2026

S 4482: WELLS Act

The WELLS Act requires hospitals, including those in rural areas, to create detailed discharge plans for pregnant patients who are expected to leave before giving birth, ensuring these plans include travel assessments and backup care options. This requirement takes effect on January 1, 2027, and mandates that hospitals discuss these plans with patients or their representatives in a language they understand. Additionally, the bill establishes a new funding program for rural training grants that must meet specific performance milestones regarding staff education and requires annual public reporting on training methods and patient outcomes. The legislation also creates a multi-center research initiative to evaluate different training models for healthcare professionals and develops a public dashboard to track maternal health metrics across federal agencies.

Topics ✓ HealthcareSupports HealthcareBill mandates discharge plans for pregnant patients and establishes funding for rural training grants, improving patient access and safety.90% confidence

Sub-Topics Hospitals Women's Health

Track

in committee · United States · House May 4, 2026

HR 8651: Advancing Safe Medications for Moms and Babies Act of 2026

This legislation directs the Food and Drug Administration to update regulations requiring the inclusion of pregnant women in clinical trials for new medications. It also mandates the National Institutes of Health to prioritize research projects focused on the safety and efficacy of drugs prescribed to pregnant and lactating women. To support these changes, the bill authorizes funding for an education campaign that informs patients and healthcare providers about available research opportunities and registries. Finally, the act requires the relevant agencies to submit work plans and progress reports to Congress regarding these regulatory and research initiatives.

Topics ✓ HealthcareSupports HealthcareBill mandates inclusion of pregnant women in clinical trials and prioritizes research on drug safety, directly improving patient access to safe treatments and protecting maternal health.95% confidence

Sub-Topics Women's Health

Track

in committee · United States · House Apr 27, 2026

HR 8521: Protect Moms From Domestic Violence Act

This bill directs the Department of Health and Human Services to study how domestic violence, sexual assault, and related traumas affect maternal health risks, including suicide, overdose, and poor birth outcomes, with a focus on diverse communities. It authorizes $15 million over three years to fund grants for states, healthcare providers, and community organizations to develop culturally relevant programs that support victims of violence during pregnancy and after childbirth. The legislation also requires the department to issue guidance within two years on how healthcare providers should routinely screen for intimate partner violence and implement trauma-informed care plans.

Topics ✓ HealthcareSupports HealthcareBill allocates $15M to fund grants for healthcare programs addressing maternal health risks and domestic violence.90% confidence

Sub-Topics Substance Abuse Women's Health

Track

in committee · United States · House May 7, 2026

HRES 1268: Recognizing the week of May 3, 2026, through May 9, 2026, as "National Postpartum Awareness Week for Communities of Color".

This House Resolution designates the week of May 3 through May 9, 2026, as National Postpartum Awareness Week for Communities of Color. It formally acknowledges the unique health challenges and disparities faced by pregnant people of color during the postpartum period. The measure does not create new laws or allocate funding but aims to raise awareness and encourage support for maternal health equity initiatives.

Topics ✓ HealthcareSupports HealthcareBill raises awareness of maternal health disparities, advocating for equity and support in postpartum care for communities of color.85% confidence

Sub-Topics Women's Health

Track

in committee · United States · Senate May 14, 2026

SRES 732: A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

This Senate resolution expresses the non-binding opinion that federal laws regarding medication abortion should rely on scientific evidence rather than political influence. It specifically calls for the FDA to maintain its approval of mifepristone, a drug proven safe and effective over 25 years, and to allow patients to access it through telemedicine or mail-order pharmacies. The measure highlights that current restrictions disproportionately harm marginalized communities, including people of color, low-income individuals, and those in rural areas. By stating these points, the resolution aims to encourage policymakers to ensure equitable and transparent access to abortion care based on medical consensus.

Topics ✓ HealthcareSupports HealthcareBill advocates for maintaining FDA approval of mifepristone and expanding patient access via telemedicine, directly supporting healthcare access and patient rights.95% confidence

Sub-Topics Telehealth Women's Health

Track

in committee · United States · Senate May 11, 2026

S 4481: IMPACT to Save Moms Act

The IMPACT to Save Moms Act authorizes a five-year demonstration project from 2027 to 2031 to test new payment models for maternity care under Medicaid and state child health plans. This initiative requires the federal government to work with various stakeholders, including hospitals, providers, and community organizations, to design systems that improve health outcomes for pregnant individuals, with a specific focus on groups facing higher risks of poor maternal health. The proposed models must include methods to adjust payments based on pregnancy risk, consider non-hospital birth settings, and ensure care teams include diverse professionals trained to address implicit bias. Additionally, the bill mandates that the project be evaluated using data on health outcomes and costs, with a final report submitted to Congress to determine if the program should be expanded nationally.

Topics ✓ HealthcareSupports HealthcareBill authorizes funding for a demonstration project to improve maternity care outcomes and expand access under Medicaid.95% confidence

Sub-Topics Children's Health Medicaid Women's Health

Track

in committee · United States · Senate Apr 16, 2026

SRES 675: A resolution supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc., to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.

This resolution supports designating April 11-17, 2026, as "Black Maternal Health Week." The designation aims to bring national attention to the maternal and reproductive health crisis in the United States, specifically emphasizing the importance of reducing maternal mortality and morbidity among Black women and birthing people.

Topics ✓ HealthcareSupports HealthcareBill designates awareness week to highlight maternal health crisis and reduce mortality among Black women, advancing public health attention and support.90% confidence

Sub-Topics Women's Health

Track

in committee · United States · House Mar 12, 2026

HR 7902: Safeguarding Women from Chemical Abortion Act

This bill, titled the Safeguarding Women from Chemical Abortion Act, aims to revoke federal approval for the drug mifepristone (also known as RU-486) for use in terminating pregnancies. If enacted, the Food and Drug Administration's approval for mifepristone for this indication would be withdrawn within 14 days, making its introduction into interstate commerce for pregnancy termination a violation of federal law. Additionally, the bill establishes a new federal right for individuals to sue manufacturers of mifepristone if they experience bodily injury or harm to mental health attributed to its use for pregnancy termination. This legislation directly affects drug manufacturers, distributors, healthcare providers, and individuals seeking or having used medication abortion.

Topics ✗ HealthcareOpposes HealthcareBill restricts access to abortion medication by revoking FDA approval, limiting patient access to reproductive healthcare services.95% confidence

Sub-Topics Mental Health Women's Health

Track

in committee · United States · House Apr 15, 2026

HR 8317: Tech to Save Moms Act

The Tech to Save Moms Act aims to improve maternal health outcomes for pregnant and postpartum individuals by increasing access to technology-enabled care. It allows states to adopt and use telehealth tools under Medicaid for screening, monitoring, and managing health complications during pregnancy and up to one year postpartum. The bill also establishes two grant programs: one to fund technology-enabled collaborative learning models for training maternal healthcare providers, especially in underserved areas, and another to increase access to digital tools that reduce maternal health disparities. Finally, it directs the National Academies to study the use of technology and patient monitoring devices in maternity care, focusing on racial and ethnic biases.

Topics ✓ HealthcareSupports HealthcareBill expands telehealth access for maternal care under Medicaid and funds provider training, directly strengthening healthcare services.95% confidence ✓ TechnologySupports TechnologyBill explicitly funds and expands technology-enabled telehealth tools for maternal care, strengthening digital health access.90% confidence

Sub-Topics Medicaid Telehealth Women's Health

Track

in committee · United States · House Apr 16, 2026

HRES 1183: Supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc. (BMMA), to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.

This House Resolution supports designating the week of April 11 through April 17, 2026, as "Black Maternal Health Week." The resolution aims to bring national attention to the maternal and reproductive health crisis in the United States, specifically highlighting the importance of reducing maternal mortality and morbidity among Black women and birthing people.

Topics ✓ HealthcareSupports HealthcareBill designates awareness week for Black Maternal Health, highlighting importance of reducing maternal mortality and morbidity, supporting public health initiatives.85% confidence

Sub-Topics Women's Health

Track